Victor Moyo
Chief Tech/Sci/R&D Officer at TRAWS PHARMA, INC.
Profile
Victor Moyo is currently the Chief Medical Officer at Traws Pharma, Inc. since 2023 and at OncoPep, Inc. since 2022.
He holds a doctorate degree from the University of Zimbabwe.
Victor Moyo active positions
Companies | Position | Start |
---|---|---|
TRAWS PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2023-10-23 |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Corporate Officer/Principal | 2022-04-30 |
Training of Victor Moyo
University of Zimbabwe | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TRAWS PHARMA, INC. | Health Technology |
Private companies | 1 |
---|---|
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |
- Stock Market
- Insiders
- Victor Moyo